The use of plasma lactate to assess metabolic or circulatory impairment requires definition of critical preanalytical and analytical parameters. Stability has been documented for only 15 mm after acquisition when samples were collected with fluoride and transported on ice. We examined time elapsed before analysis, storage temperature, and the antiglycolytic agent used to define preanalytical conditions. Plasma lactate was measured with a Kodak Ektachem 700XR analyzer. In controlled studies on volunteers, storage on ice slowed but did not eliminate the production of lactate; for samples collected with sodium fluoride (F) and potassium oxalate ( 
Glycolysis
continues in blood after phlebotomy. Because erythrocytes do not contain mitochondria, the pyruvate formed by glycolysis cannot enter the tricarboxylic acid cycle. However, the reduction of pyruvate to lactate by lactate dehydrogenase with concurrent oxidation of NADH to NAD allows glycolysis to continue. The resulting decrease in blood glucose is paralleled by a time-and temperature-dependent increase in lactate concentration.
The rate of decrease of glucose from whole blood is not influenced by the insulin or initial glucose concentrations (1), and has been reported as 6 mg/dL per hour at room temperature (0.36 mmol/L per hour) (2). Although this decrease in glucose is arguably significant, the corresponding 0.7 mmol/L per hour increase in lactate is unacceptable, given its relatively narrow reference interval (0.
5-2.2 mmol/L) (3).
Cumbersome early methods for lactate stabilization involved a precipitating agent to denature the cellular glycolytic enzymes before filtration (4) or centrifugation (5). Chilling the sample on ice has not been sufficient to prevent significant increases in lactate unless an enzyme inhibitor is added. Since Huckabee promoted the probable hypoxia (n = 10), renal insufficiency (n = 5), hepatic insufficiency (n = 2), or alcohol ingestion (n = 1). These diagnoses were made after consulting each patient's physician and were considered to be consistent with their test results. A 5-mL grey-top Vacutainer#{174} Tube (Becton Dickinson, Rutherford, NJ) containing 12.5 mg of F and 10 mg of OX was filled without venous stasis. The samples were delivered on ice to the laboratory within 30 mmii. After centrifugation the samples were processed immediately and lactate was measured on an Ektachem 700 analyzer (Eastman Kodak, Rochester, NY). The Ektachem lactate method includes lactate oxidase in the reagent layer to produce hydrogen peroxide from the oxidation of lactate to pyruvate.
Peroxide oxidizes a chromogen in the presence of horseradish peroxidase to a dye complex that is measured by reflectance at 540 nm. After initial analysis, the samples were maintained at room temperature for as long as 48 h before reanalysis.
The excess plasma was maintained in contact with the cells. No attempt was made to resuspend the cells after centrifugation.
In a separate study we compared lactate stability with and without F/OX in granulocytotic samples (23 x 1O-52 x 109/L). Three of the patients had been treated with granulocyte colony-stimulating factor. The fourth patient had a leukemoid reaction to a renal cell carcinoma. Whole EDTA-anticoagulated blood was aliquoted within 45 mm after collection into Microtainer#{174}Tubes (Becton Dickinson) with and without F/OX. The allquota were stored at room temperature and centrifuged just before analysis at 15 000g for 5 miii in a Microfuge#{174} centrifuge (Beckman, Brea, CA).
Temperature effects with and without inhibitor. Blood was obtained from three normal healthy volunteers to assess the effect of temperature on lactate stability in whole blood. Two of the subjects performed vigorous forearm exercise for 2 mm before sampling to increase the lactate concentration.
Simultaneously, the stability of F/OX vs heparinized plasma without any antiglycolytic agent was compared. Two 5-mL Vacutauner Tubes with 72 USP units of lithium heparin (Becton Dickinson) were drawn, mixed, and immediately placed on ice. Two 5-mL F/OX tubes were also collected and the tubes were treated as above. To minimize bias in the sampling, the second and third tubes contained F/OX; the first and fourth did not. The heparinized blood was pooled and aliquoted as 1-mL fractions in 2-mL polypropylene tubes; the F/OX blood was treated similarly. The blood was kept on ice until all processing was complete (<10 miii); some aliquots were then separated for storage at room temperature.
Just before analysis the aliquots were centrifuged Further, each LEP test matrix was diluted with appropriate EP to achieve lactate concentrations of 1,2,4, 6, 8, and 10 mmol/L.
Results and Discussion
Aliquots of plasma samples from patients were obtained and analyzed immediately upon arrival in the laboratory.
The plasma remained in contact with the cells until sampling for lactate analysis at various times up to 48 h after phlebotomy.
A two-tailed paired t-test showed a significant increase (P = 0.0001) in lactate concentration at 24 h. However, the mean increase in lactate for all patients was only 0.15 (0-0.3) mmol/L. Heparinizedblood was obtained from a normal volunteer and then splitinto aliquots thatreceived60 mmol/LF (0), 12 mmol/LOX (C), both additives (+), or neither(U). increase was from a patient who had a baseline lactate concentrationof 1.7 that increased to 2.0 mmol/L. Figure 1 shows the stability of lactate in whole blood from patients with granulocytosis when obtained with and without F/OX. At 8 h the mean increase in lactate without F/OX was 6.4 mmol/L (3.7,5.0, 7.0, and 9.9), and was generally higher than the increases observed with blood from healthy volunteers (see Table 2 ). The mean increase with F/OX was 0.3 mmol/L (0.1-0. Interestingly, when F/OX was used, most of the increase occurred in the first hour, regardless of the temperature.
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The relative ability of OX alone to stabilize lactate in heparinized whole blood stored at room temperature was investigated.
The results are summarized in Fig. 2 . The addition of OX alone, although not as effective as F, appeared to retard the production of lactate. This experiment suggested that OX was either acting as an inhibitor of lactate production or causing proportional interference in the assay. To investigate the former possibility, we prepared EP with and without lactate. Dilutions were made so as to keep the OX or F concentration constant at each dilution while also keeping the matrix constant. The lactate concentration was varied from 1 to 10 mmolJL. As seen in Fig. 3 , neither additive caused a bias.
In conclusion, F/OX-preserved plasma is approprmte for lactate determinations on the Kodak Ektachem analyzer. Neither additive caused an interference in the method.
OX inhibited lactate production, consistent with its reported competitive inhibition of pyruvate kinase (21). Storage on ice provides no additional stabilization when blood is properly obtained in tubes containing F/OX. Thus, whole blood collected with these preservatives need not be stored on ice while being transported to the laboratory. Even with F/OX as a stabilizer there was a 0.2 mmol/L increase in lactate during the first hour, regardless of the temperature. These results suggest that it is unlikely that misdiagnosis of lactic acidemia will occur if samples are collected in F/OX tubes, even if analysis is delayed for up to 8 h at room temperature.
The mean increase in lactate was only 0.3 mmol/L after 8 h in samples obtained from healthy volunteers and from patients with leukocytosis; in the patients being evaluated for possible lactic acidosis the increase in lactate was -0.15 mmol/L at 24 h.
